These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6628930)

  • 21. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease.
    Hocke M; Richter L; Bosseckert H; Eitner K
    Hepatogastroenterology; 1999; 46(28):2333-7. PubMed ID: 10521992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of inflammatory activity in Crohn's disease.
    Lamers CB; Biemond I; van der Sluys Veer A; van Hogezand RA
    Neth J Med; 1994 Aug; 45(2):52-4. PubMed ID: 7936005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation of C-reactive protein with activity of Crohn's disease].
    Yang CH; Chen XY; Yang F; Ran ZH; Liu WZ; Xiao SD
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1253-5. PubMed ID: 16796884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
    Kapsoritakis AN; Koukourakis MI; Sfiridaki A; Potamianos SP; Kosmadaki MG; Koutroubakis IE; Kouroumalis EA
    Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Crohn's disease activity index" is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.
    Viscido A; Corrao G; Taddei G; Caprilli R
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):274-9. PubMed ID: 10425569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [111In-oxine-labeled granulocytes in Crohn disease and ulcerative colitis. Labeling and study technics].
    Becker W; Fischbach W; Reiners C; Börner W
    Rofo; 1985 Mar; 142(3):320-5. PubMed ID: 2984737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
    Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [111In-oxine marked leukocytes: a method for diagnosing the location and evaluating the activity of Crohn disease and ulcerative colitis].
    Becker W; Fischbach W; Reiners C; Börner W
    Z Gastroenterol; 1985 Oct; 23(10):557-64. PubMed ID: 3936291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
    Erichsen K; Ulvik RJ; Nysaeter G; Johansen J; Ostborg J; Berstad A; Berge RK; Hausken T
    Scand J Gastroenterol; 2005 Sep; 40(9):1058-65. PubMed ID: 16165718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.
    Targan SR; Feagan BG; Fedorak RN; Lashner BA; Panaccione R; Present DH; Spehlmann ME; Rutgeerts PJ; Tulassay Z; Volfova M; Wolf DC; Hernandez C; Bornstein J; Sandborn WJ;
    Gastroenterology; 2007 May; 132(5):1672-83. PubMed ID: 17484865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease?
    Crama-Bohbouth G; Pena AS; Biemond I; Verspaget HW; Blok D; Arndt JW; Weterman IT; Pauwels EK; Lamers CB
    Gut; 1989 Sep; 30(9):1236-40. PubMed ID: 2806991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Faecal calprotectin in the assessment of Crohn's disease activity.
    Gaya DR; Lyon TD; Duncan A; Neilly JB; Han S; Howell J; Liddell C; Stanley AJ; Morris AJ; Mackenzie JF
    QJM; 2005 Jun; 98(6):435-41. PubMed ID: 15879440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological measurements of Crohn's disease activity--a reassessment.
    André C; Descos L; André F; Vignal J; Landais P; Fermanian J
    Hepatogastroenterology; 1985 Jun; 32(3):135-7. PubMed ID: 2410345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of fecal granulocyte excretion in ulcerative colitis and Crohn's colitis.
    Saverymuttu SH; Hodgson HJ; Chadwick VS
    Dig Dis Sci; 1984 Nov; 29(11):1000-4. PubMed ID: 6489079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differing acute phase responses in Crohn's disease and ulcerative colitis.
    Saverymuttu SH; Hodgson HJ; Chadwick VS; Pepys MB
    Gut; 1986 Jul; 27(7):809-13. PubMed ID: 3732890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of delayed indium-111 labeled leukocyte scan in the management of Crohn's disease.
    Slaton GD; Navab F; Boyd CM; Diner WC; Texter EC
    Am J Gastroenterol; 1985 Oct; 80(10):790-5. PubMed ID: 4036938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
    Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD
    Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.